DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment (Q37072060)

18 August 2017

1 reference

title

DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment (English)

1 reference

18 August 2017

0 references

0 references

1 reference

3

Susan J Clark

1 reference

18 August 2017

Caroline A Barton

1

1 reference

18 August 2017

Neville F Hacker

series ordinal

2

1 reference

18 August 2017

Philippa M O'Brien

series ordinal

4

1 reference

18 August 2017

language of work or name

English

0 references

publication date

29 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

109

1 reference

18 August 2017

1

1 reference

18 August 2017

129-139

1 reference

18 August 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetics: regulation through repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

The fundamental role of epigenetic events in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

CpG-rich islands and the function of DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

CpG islands in vertebrate genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

DNA methylation and gene silencing in cancer: which is the guilty party?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

7 January 2021

Epigenetics and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

DNA methylation in cancer: too much, but also too little

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Cancer epigenetics comes of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Gene silencing in cancer in association with promoter hypermethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetics in human disease and prospects for epigenetic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Transcription of IAP endogenous retroviruses is constrained by cytosine methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

The history of cancer epigenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Differential methylation of human LINE-1 retrotransposons in malignant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Chromosomal Instability and Tumors Promoted by DNA Hypomethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Induction of Tumors in Mice by Genomic Hypomethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Tumor Cell-SpecificBRCA1andRASSF1AHypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic regulation of ARHI in breast and ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Inactivation of BRCA1 and BRCA2 in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Promoter methylation status and expression of TMS1 gene in human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic inactivation of TMS1/ASC in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Promoter hypermethylation profile of ovarian epithelial neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic regulation of maspin expression in human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Human l1 retrotransposition is associated with genetic instability in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Hypomethylation of pericentromeric DNA in breast adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

DNA hypomethylation and ovarian cancer biology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

The power and the promise of DNA methylation markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

MethyLight: a high-throughput assay to measure DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Headloop suppression PCR and its application to selective amplification of methylated DNA sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation changes in faecal DNA: a marker for colorectal cancer screening?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Sensitive Detection of DNA Methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation of death-associated protein kinase in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation profiling of CpG islands in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Prognostic DNA methylation biomarkers in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

The epigenetics of ovarian cancer drug resistance and resensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Aberrant DNA methylation in ovarian cancer: is there an epigenetic predisposition to drug response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic events in the colorectum and in colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

DNA methylation changes in leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Cancer epigenomics: DNA methylomes and histone-modification maps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Detection and interpretation of altered methylation patterns in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Identification of candidate methylation-responsive genes in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Genomic sweeping for hypermethylated genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic therapy of cancer: past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Frequency of BRCA1 dysfunction in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation profile in benign, borderline and malignant ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Combined analysis of p53 and RB pathways in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

CDKN2A gene inactivation in epithelial sporadic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic and genetic alterations of p33ING1b in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Mismatch repair and treatment resistance in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Silencing of the UCHL1 gene in human colorectal and ovarian cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.12.017

10.1016/J.YGYNO.2007.12.017

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference